Clinical Trial Update: Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia [EARLY_Phase 1]

View source ↗

Summary

A clinical trial is investigating whether levocarnitine can reduce asparaginase-associated hepatotoxicity in patients with acute lymphoblastic leukemia; the ear…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Asparaginase (asparaginase)
• LEVOCARNITINE (levocarnitine)

Snippet

Sponsor: Children's Hospital of Orange County | Conditions: Acute Lymphoblastic Leukemia, Hepatotoxicity | EARLY_Phase 1 | Status: RECRUITING